More Investing
View Older Stories View Newer Stories-
Bath Body shares dip as guidance for current quarter falls short; Q4 results ahead
-
Nvidia plunges over 8% post earnings on profit-taking, margin worries
-
Salesforce shares dip premarket on softer-than-expected guidance
-
eBay shares tumble as Q1 revenue guidance disappoints
-
Snowflake stock leaps over 10% on earnings beat, bullish annual forecast
-
Eli Lilly to invest another $27 billion in U.S. manufacturing
-
Trump discusses China relations, tariffs, and Ukraine War at first cabinet meeting
-
Ingevity Corporation 'EPS/FCF growth to drive stock': BMO Capital
-
STAK Inc. IPO opens at $3.62 after $4.00 pricing
-
AppLovin tumbles 15% after Culper Research discloses short position
-
Bernstein upgrades Alibaba on AI optimism
-
Icahn Enterprises reports Q4 net loss of $98 million, beats estimates
-
NRG Energy shares pop as Q4 profit comes ahead of estimates
-
Krispy Kreme cut to sell at Morgan Stanley as 2025 guidance 'materially worse'
-
Stellantis shares slide lower on soft H2 results, loose guidance
-
Lucid shares jump on strong 2025 vehicle production outlook; CEO steps down
-
Auto1 Group shares spike on better-than-anticipated fourth-quarter earnings
-
AstraZeneca breast cancer drug shows positive results, shares up
-
GM approves new share buyback, dividend increase
-
Boeing (BA) announces executive changes, board reduction
-
Supermicro stock surges after filing delayed reports
-
US oil futures climb slightly after API reports surprise draw in crude stockpiles
-
Cava Group posts surprise profit, beats revenue estimates but shares slump
-
Intuit fiscal Q2 results top estimates, reiterates FY guidance; lifts dividend
-
First Solar shares down as Q4 profit miss, issues 2025 guidance below expectations
-
Teva (TEVA) and Medincell Announce FDA Acceptance of sNDA for UZEDY Extended-Release Injectable Suspension as a Treatment for Patients with Bipolar I Disorder
-
Workday stock soars 8% on earnings beat, strong guidance
-
Live Nation (LYV) stock drops amid FTC breakup comments
-
Porsche announces executive board reshuffle
-
Maze Therapeutics receives positive ratings following recent IPO
-
Warner Bros. Discovery (WBD) shuts down three game studios, halts Wonder Woman game - Bloomberg
-
Snowflake target raised at Canaccord ahead of earnings
-
Wall Street bullish on Metsera following January IPO on obesity drug pipeline
-
Bank of America’s preview of 3M investor day
-
Wall Street analysts upbeat on CyberArk’s investor day targets
-
Morgan Stanley sees FDA approval of GILD's Lenacapavir
-
Argus cuts Domino’s rating to hold on cost pressures, weak U.S. sales
-
Morgan Stanley bullish on Progressive, lifts EPS estimate
-
JP Morgan cuts Tempus AI rating to ‘neutral’ after stock’s sharp rally
-
Lilly unveils higher vial doses of obesity drug that are cheaper than injector pen
-
Block valuation now 'reflective of risks': Morgan Stanley
-
CDPQ to buy renewable power company Innergex in $10 billion deal
-
Paypal shares up after earnings outlook
-
Donut chain Krispy Kreme unveils disappointing guidance, sending shares tumbling
-
Novo shares rise as HIMS halt sales of some obesity drugs
-
Unilever shares down on CEO Hein Schumacher's exit
-
European markets mixed as Germany's economy contracts; Unilever CEO steps down
-
Crypto stock including MicroStrategy, Coinbase, Riot fall after BTC below $90k
-
Alibaba, US-listed Chinese stocks rebound after sharp Monday sell-off
-
Cleveland-Cliffs shares down on wider-than-expected loss
